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Reply by Hemilä: 
 
Dr Bates makes five specific criticisms of my recent paper (Hemilä, 1997a) to which I shall respond 
separately: 
 
1. When a person carries out twenty different subgroup analyses and finds that only one yields a 
statistically significant result (P?0.05), the finding must be interpreted very cautiously as it is 
likely to be caused by chance alone. However, to use the same logic to explain the P value in my 
Table 2 for the British male studies would imply that I had carried out some 1,000,000 kinds of 
selections of vitamin C studies and simply picked the best one. Such an explanation of the small P 
value is improbable in the extreme. 
A highly significant difference in common cold incidence between vitamin C and placebo groups 
(P = 0.00003) was also found in a meta-analysis of three randomized double-blind trials involving 
subjects under heavy acute physical stress (Hemilä, 1996a). Furthermore, a diet deficient in vitamin C 
increases the susceptibility of guinea pigs to infections, and in several controlled studies with human 
subjects vitamin C supplementation had effects on infections other than the common cold (Hemilä, 
1997b,c). Thus the British male studies do not constitute an isolated group inconsistent with all other 
available data, but form one piece in a larger mosaic indicating that vitamin C influences the function of 
the immune system. 
 
2. In examining the results of several studies on the same topic concurrently the direction of the effect 
being considered must be decided on, and one-tailed P values are thus appropriate (Rosenthal, 
1978; Wolf, 1986). For example, if one study finds a decrease and another finds an increase in the same 
phenomenon, it makes no sense to compare the two studies on the basis of two-tailed P values. If there 
are results pointing strongly in opposite directions there is obviously no wisdom in combining them 
formally or informally. Nevertheless, I am not aware of studies in which a significantly higher number of 
colds was observed in a group administered vitamin C. 
In my paper I provided confidence intervals (CI) as a measure of precision and not as a test of the 
null hypothesis. One-tailed P = 0.05 corresponds to two-tailed P = 0.10, which itself corresponds to the 
90 % CI with one limit at the null hypothesis level (Altman, 1991). While the 95% CI is most 
commonly used and the 90% CI is slightly narrower, the difference has no practical relevance in my 
tables. 
 
3. In a long-lasting controversy, positive and negative findings are both newsworthy. For example, 
while Glazebrook & Thomson (1942), Walker et al. (1967), Carson et al. (1975), Elwood et al. (1976) 
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and Tyrrell et al. (1977) all explicitly drew rather negative conclusions as to their findings on vitamin 
C and the common cold, the papers were nevertheless written and published. 
The possible role of publication bias can be quantified by calculating the fail-safe N, which refers 
to the number of similar studies finding no difference which should remain unpublished with the effect 
of collectively reversing the conclusion that a statistically significant difference exists (Rosenthal, 1979; 
Light & Pillemer, 1984; Wolf, 1986). In the case of the four male studies in my Table 2, the fail-safe n is 
31 unpublished studies finding no difference. Although this kind of measure is imprecise, publication 
bias seems not to be of major concern. Finally, it seems incomprehensible that publication bias would 
generate the substantial difference between the sexes. 
 
4. There is only a slight difference between the two male groups of Baird et al. (1979) who were 
administered 80 mg vitamin C/d, and the difference is not in favour of orange juice. The number of 
cold episodes was ninety-one and ninety-three among the male subjects administered 80 mg/d in 
orange juice (n 62) and in synthetic drink (n 71) respectively, yielding RR = 0.89 (95% CI: 0.67, 
1.19) in favour of the synthetic drink. Since the difference is small and statistically insignificant, it 
seems appropriate to combine the two groups who were administered the same vitamin C dose. 
The comparison between the synthetic drink containing 80 mg vitamin C/d and the synthetic drink 
lacking the vitamin yields RR = 0.59 (95 % CI: 0.45, 0.77) for males, which is essentially the same as 
in my Table 2. 
Bates claims that the incidence of colds was extraordinarily high in the study by Charleston & 
Clegg (1972), but the data in my Tables 1 and 2 contradict such a suggestion. The incidence rate was 
6.2/year in the Charleston & Clegg (1972) male placebo group, but 11.2/year in the Baird et al. (1979) 
male placebo group and 7.2/year in the Elwood et al. (1976) female placebo group. The incidence was 
also higher in the large-scale trials by Ludvigsson et al. (1977) and Pitt & Costrini (1979). 
Since there is evidence indicating that the effects of vitamin C on the immune system are based on 
its antioxidant role (Hemilä, 1992a, 1997b), the L- and D-isomers may both affect the immune system. 
In particular, Bissell et al. (1980) found similar suppression of viral replication in cell culture with L- 
and D-ascorbic acid. Accordingly, in the current state of knowledge it seems reasonable to combine the 
Clegg & Macdonald (1975) L- and D-isomer groups. 
I do not discount the study by Glazebrook & Thomson (1942). As a form of sensitivity analysis I 
tested the effect of excluding their study as it is technically the most deficient among those in Table 2. 
However, the exclusion did not reduce the difference between the vitamin C and control groups, but 
made it greater. The Glazebrook & Thomson trial does have shortcomings but I see no reason to 
disregard it. The authors explicitly paid careful attention to the comparability of the study groups. 
Neither does it seem likely that vitamin C added to food in a kitchen would generate a substantial 
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placebo effect in the dining hall. Furthermore, they did find a statistically significant decrease in the 
number of colds in their vitamin C group (P = 0.048; one-tailed ?2 -test). 
Finally, Bates's commentary ignored the randomized double-blind trial by Tyrrell et al. (1977) 
which found a significant decrease in the number of men with recurrent colds when vitamin C was 
administered during their first cold episode (P = 0.018; one-tailed ?2-test). 
 
5. Since what is biologically plausible depends upon the biological knowledge of the day, the 
understanding of a physiological mechanism usually is not crucial in drawing inferences on causal 
relationships in epidemiology. For example, the notion that smoking causes lung cancer was originally 
derived from observational epidemiological studies and the earliest conjectures on the biological 
mechanism were completely erroneous (Hennekens & Buring, 1987). Moreover, it took some five 
decades after the emergence of the first epidemiological findings before a direct aetiological link between 
smoking and lung cancer could be shown at the biochemical level (Denissenko et al. 1996). 
Nevertheless, in my paper I explicitly cite studies reporting effects of vitamin C on the immune 
system and there are several other similar publications (Hemilä, 1997b). Bates' opinion that the 
mechanism whereby vitamin C might affect susceptibility to infections is merely speculative misses the 
point entirely. 
The biochemical mechanism whereby vitamin C deficiency produces the pathological defects in 
scurvy is not well understood, and in particular the usual textbook reference to poor hydroxylation of 
collagen is a gross oversimplification, if valid at all (Englard & Seifter, 1986). However, I do not think 
it would be appropriate to describe the present understanding as purely speculative or to conclude that 
vitamin C has no effect on scurvy because the biochemistry has not yet been completely elucidated. 
 
After his specific criticisms, Bates offered some general opinions on nutritional recommendations. He 
suggested that the effects of micronutrients should be considered primarily in the light of human 
intervention studies, a viewpoint which I heartily endorse. However, such an approach has not been 
applied in the official monographs on these issues. 
In the British recommendations no mention is made of the vitamin C and common cold link 
(Department of Health, 1991) although more than sixty intervention studies have been published on 
the issue (Kleijnen et al. 1989). In fact, one of the studies cited in the UK recommendations 
reported that the geometric mean duration of colds was 6.4 days in vitamin C-deprived subjects and 
3.3 days in non-deprived subjects, and the authors concluded that the absence of vitamin C tended to 
cause colds to last longer (Bartley et al. 1953). The brief comment on the vitamin C and plasma 
cholesterol relationship is based on one single uncontrolled study (Department of Health, 1991) 
although over thirty intervention studies have been published, eleven of which were placebo-controlled 
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(Hemilä, 1992b). 
The lack of thoroughness in reviewing the literature is not a problem restricted to the UK 
recommendations but is also apparent in the US recommendations (National Research Council, 1989). 
For example, the conclusion that vitamin C has no meaningful effect on the common cold is based on the 
reviews by Chalmers (1975) and by Dykes & Meier (1975). However, both reviews contain serious 
errors which should have been recognized by the authors of the monograph had they been familiar 
with the intervention study reports (Hemilä & Herman, 1995; Hemilä, 1996b). The conclusion that 
vitamin C has no effect on cholesterol metabolism is based on a single uncontrolled study (National 
Research Council, 1989) and no reference is given to the placebo-controlled trials, some of which 
reported a significant difference between the vitamin C and placebo groups (Hemilä, 1992b, 1993). 
Because of the prominent political dimension of the nutritional recommendations there is evidently 
considerable incentive to oversimplify these complex issues and to be conservative as regards new 
findings. In the popular literature there are numerous, obviously false, claims about the benefits of 
vitamin C supplementation and such claims are utilized commercially; in this respect a conservative 
attitude in the nutritional recommendations is understandable. Nevertheless, such political concerns 
should not bias investigation of the actual scientific questions and provide no valid reason to ignore the 
intervention studies examining the effect of vitamin C on the common cold and on plasma cholesterol 
level, and a large number of intervention studies on other topics, some of which were reviewed by Basu 
& Schorah (1982). Furthermore, when a large number of studies have examined the same issue there is 
considerable risk that important points are not recognized easily, which underscores the importance of a 
systematic approach (Light & Pillemer, 1984; Wolf, 1986). However, in the case of vitamin C a 
systematic method of reviewing the literature was not applied (National Research Council, 1989; 
Department of Health, 1991). 
As regards the safety of vitamin C supplementation, much speculation about potential harm has 
been advanced, but it has been shown to be unfounded (Rivers, 1987; Marks, 1989; Hemilä, 1994; 
Bendich & Langseth, 1995). Since none of the common cold studies (Hemilä 1992a) in which 1?3 g 
vitamin C/d was regularly administered to over 3000 subjects in all reported any meaningful 
difference in the occurrence of adverse symptoms between the vitamin and placebo groups, the safety 
of vitamin C in the 0.1?1 g/day range is no real concern. Obviously, argument for higher intakes cannot 
be based on safety alone, but must include sound evidence of benefit. 
There are findings suggesting that in doses higher than those officially recommended, vitamin C 
may be beneficial for certain population groups as regards conditions other than scurvy. Nevertheless, we 
have no real understanding of who these subpopulations are, what the magnitude of the effect is, and 
what kind of dose would be best. If the subpopulations are small there is no point in recommending 
higher intakes for the general population. Table 1 of my paper indicates that the British male studies 
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should not produce over-optimism as to the effect of vitamin C on the incidence of colds (Hemilä, 
1997a). The effect of vitamin C on the symptoms of colds has usually been modest (Hemilä, 1992a). 
Nonetheless, the common cold is such a ubiquitous ailment that even quite a modest effect may be worth 
exploitation, and it is possible that there are effects on other conditions to be considered (Stone, 1972; 
Basu & Schorah, 1982; Hemilä, 1992b; Bielory & Gandhi, 1994; Bendich & Langseth, 1995; Hemilä, 
1997b,c). 
The possibility of publication bias and various technical shortcomings in the published studies 
should not discourage us from planning and carrying out carefully designed trials which address these 
questions more explicitly. The findings of such trials would provide a more solid scientific basis for 
further discussions about the appropriate intake levels. 
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